1. Academic Validation
  2. Semi-synthesis and anti-tumor activity of novel 25-OCH3-PPD derivatives incorporating aromatic moiety

Semi-synthesis and anti-tumor activity of novel 25-OCH3-PPD derivatives incorporating aromatic moiety

  • Bioorg Med Chem Lett. 2019 Jan 15;29(2):189-193. doi: 10.1016/j.bmcl.2018.12.003.
Fan-Zhi Qu 1 Sheng-Nan Xiao 1 Xu-De Wang 1 Yan Zhang 1 Guang-Yue Su 2 Yu-Qing Zhao 3
Affiliations

Affiliations

  • 1 Shenyang Pharmaceutical University, Shenyang 110016, China.
  • 2 Shenyang Pharmaceutical University, Shenyang 110016, China; Key Laboratory of Structure-based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China.
  • 3 Shenyang Pharmaceutical University, Shenyang 110016, China; Key Laboratory of Structure-based Drug Design and Discovery of Ministry of Education, Shenyang Pharmaceutical University, Shenyang 110016, China. Electronic address: zhaoyuqing@syphu.edu.cn.
Abstract

Previously we have reported that 25-OCH3-PPD could suppress the reproduction of Cancer cells and cause Apoptosis without obvious toxicity. Herein, we aimed to enhance its bioactivity by introducing aromatic groups to its dammarane-type skeleton. These synthesized derivatives were tested for their inhibitory activities against five Cancer cell lines. Of them, compounds 3a, 14a and 18a had the strongest antiproliferative activities against tumor cells (IC50 < 15 µM, 5-fold to 10-fold increases than 25-OCH3-PPD). Especially compound 14a displayed the most potent activity against DU145, MCF-7 and HepG2 cells (IC50 = 6.7 ± 0.8, 4.3 ± 0.8 and 5.8 ± 0.6 µM, respectively). Structure-activity relationships demonstrated that having aromatic ester at the C3 position could improve the bioactivity. The data provided new insights into exploring novel antiproliferative lead compounds.

Keywords

25-OCH(3)-PPD; Anti-tumor activity; Aromatic ring; Structure-activity relationships.

Figures